I13.11, Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal diseaseICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L34338, Transthoracic Echocardiography (TTE)
J15
CGS-J15-L40386, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L34356, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L33959, Cardiac Catheterization and Coronary Angiography
J15
CGS-J18-L34356, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L34338, Transthoracic Echocardiography (TTE)
J18
CGS-J18-L40386, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L33959, Cardiac Catheterization and Coronary Angiography
J18
WPS-J5-L34633, Erythropoiesis Stimulating Agents (ESAs)
J5
WPS-J5-L35755, Non-Invasive Abdominal / Visceral Vascular Studies
J5
WPS-J5-L35998, Non-Coronary Vascular Stents
J5
A57590, Billing and Coding: Non-Coronary Vascular Stents
J5
A54923, Billing and Coding: Bariatric Surgery for Treatment of Co-Morbidities Conditions Related to Morbid Obesity
J5
A57591, Billing and Coding: Non-Invasive Abdominal / Visceral Vascular Studies
J5
A56795, Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
J5
NGS-J6-L33577, Transthoracic Echocardiography (TTE)
J6
NGS-J6-L33557, Cardiac Catheterization and Coronary Angiography
J6
A52850, Billing and Coding: Cardiac Catheterization and Coronary Angiography
J6
NGS-J6-L40334, Erythropoiesis Stimulating Agents
J6
NGS-J6-L40333, Erythropoiesis Stimulating Agents
J6
Ask Backwork about documentation requirements, denial risks, or coverage in your state.